上海家化(600315) - 2020 Q3 - 季度财报

Financial Performance - Net profit attributable to shareholders of the listed company was ¥312,117,140.45, a decrease of 42.25% year-on-year[18]. - Operating revenue for the first nine months was ¥5,362,181,119.25, down 6.51% from the same period last year[18]. - Basic earnings per share decreased by 43.21% to ¥0.46[21]. - The weighted average return on net assets fell by 4.04 percentage points to 4.91%[21]. - The net profit after deducting non-recurring gains and losses was ¥276,061,476.87, down 27.34% year-on-year[18]. - The net profit attributable to shareholders for the third quarter was RMB 312,117,140.45, a decrease of 42.25% compared to RMB 540,429,290.65 in the same period last year[39]. - Basic and diluted earnings per share were both RMB 0.46, down 43.21% from RMB 0.81 in the previous year[39]. - Total operating revenue for Q3 2020 was ¥1,677,542,476.13, a decrease of 7.4% compared to ¥1,812,648,519.27 in Q3 2019[62]. - Total operating costs for Q3 2020 were ¥1,625,262,520.47, down 5.1% from ¥1,712,205,821.32 in Q3 2019[62]. - Net profit for Q3 2020 reached ¥128,689,355.85, an increase of 33.4% compared to ¥96,493,284.80 in Q3 2019[65]. - Total comprehensive income for the first three quarters of 2020 was ¥229.18 million, compared to ¥784.33 million in the same period of 2019[71]. Assets and Liabilities - Total assets at the end of the reporting period reached ¥11,380,122,000.51, an increase of 2.09% compared to the end of the previous year[18]. - Total current assets increased to ¥6,412,081,802.26 as of September 30, 2020, up from ¥5,877,515,860.01 on December 31, 2019, representing an increase of approximately 9.05%[47]. - Total non-current assets decreased to ¥4,968,040,198.25 from ¥5,269,976,676.30, a decline of about 5.73%[51]. - Total current liabilities increased to ¥3,146,253,490.00 from ¥2,865,015,492.68, an increase of about 9.83%[51]. - Total liabilities rose to ¥5,041,318,200.86, compared to ¥4,861,742,472.71, indicating an increase of approximately 3.69%[53]. - Shareholders' equity increased to ¥6,338,803,799.65 from ¥6,285,750,063.60, representing a growth of about 0.85%[53]. - The company’s total liabilities were approximately ¥4.86 billion as of September 30, 2020[91]. - Current liabilities totaled approximately ¥2.87 billion, with accounts payable at ¥823.86 million[88]. - Non-current liabilities were approximately ¥1.99 billion, with long-term borrowings at ¥1.14 billion[91]. Cash Flow - Net cash flow from operating activities for the first nine months was ¥617,946,645.91, a decline of 14.72% compared to the previous year[18]. - Total cash inflow from operating activities was ¥6,010,845,130.87, down from ¥6,217,935,793.93 in the previous year, reflecting a decline of 3.34%[76]. - Cash outflow from operating activities totaled ¥5,392,898,484.96, slightly lower than ¥5,493,357,992.65 in 2019, indicating a decrease of 1.83%[76]. - Cash inflow from investment activities amounted to ¥3,917,555,081.78, an increase of 34.1% compared to ¥2,923,146,437.46 in the previous year[79]. - The net cash flow from investment activities was -¥267,847,342.09, worsening from -¥218,296,713.92 in the same period last year[79]. - Cash inflow from financing activities was ¥1,072,316,400.00, compared to ¥34,818,440.00 in the previous year, showing a significant increase[79]. - The ending balance of cash and cash equivalents was ¥1,530,899,867.17, up from ¥1,396,922,023.05 at the end of the previous year[79]. Shareholder Information - The total number of shareholders at the end of the reporting period was 26,808[26]. - The largest shareholder, Shanghai Jahwa United Co., Ltd., held 317,132,527 shares, accounting for 47.25% of the total[26]. Research and Development - Development expenses decreased by 83.31%, from RMB 10,003,015.04 to RMB 1,669,846.77, as some R&D projects were completed and transferred to intangible assets[37]. - Research and development expenses for Q3 2020 were ¥31,634,063.31, a decrease of 20.6% from ¥39,803,955.29 in Q3 2019[62]. - The company plans to continue focusing on R&D and market expansion strategies to enhance future growth[71].